Skip to content

   Pharma Publications

Neuropsychopharmacology
  • In Memoriam George K. Aghajanian, M.D. 1932 -2023
    Published on 2023-09-18
    3 years ago
  • Gene–brain–behavior mechanisms underlying autism spectrum disorder: implications for precision psychiatry
    Published on 2023-09-16
    3 years ago
  • People who binge drink show neuroendocrine tolerance to alcohol cues that is associated with immediate and future drinking- results from a randomized clinical experiment
    Published on 2023-09-16
    3 years ago
  • Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
    Published on 2023-09-15
    3 years ago
  • Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia
    Published on 2023-09-15
    3 years ago
  • Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
    Published on 2023-09-14
    3 years ago
  • Practical recommendations to improve retention of underrepresented minorities in science and medicine: an early career perspective
    Published on 2023-09-11
    3 years ago
« Previous 1 … 110 111 112 113 114 … 143 Next »
Journal of Psychopharmacology
  • Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
    Published on 2020-09-10
    6 years ago
  • Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale
    Published on 2020-09-09
    6 years ago
  • Antidepressant responses in direct comparisons of melancholic and non-melancholic depression
    Published on 2020-09-09
    6 years ago
  • Neurobiological mechanisms associated with antipsychotic drug-induced dystonia
    Published on 2020-09-09
    6 years ago
  • The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial
    Published on 2020-08-28
    6 years ago
  • The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction
    Published on 2020-08-28
    6 years ago
  • An acetylcholinesterase inhibitor, donepezil, increases anxiety and cortisol levels in adult zebrafish
    Published on 2020-08-28
    6 years ago
« Previous 1 … 110 111 112 113 114 … 150 Next »
European Neuropsychopharmacology
  • Neuromodulation; TMS (Transcranial Magnetic Stimulation) and the other Non Invasive Brain Stimulation (NIBS) in the era of brain connectivity
    Published on 2021-03-19
    5 years ago
  • Serum profiling of anorexia nervosa: A 1H NMR-based metabolomics study
    Published on 2021-03-18
    5 years ago
  • High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study
    Published on 2021-03-16
    5 years ago
  • Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C
    Published on 2021-03-16
    5 years ago
  • The role of digital medicine in autism spectrum disorder
    Published on 2021-03-16
    5 years ago
  • Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD
    Published on 2021-03-15
    5 years ago
  • Assessment of outcomes in autism clinical trials over the course of development
    Published on 2021-03-15
    5 years ago
« Previous 1 … 110 111 112 113 114 … 168 Next »

   Pharma Pub